Belatacept Conversion in Kidney Transplant: With or without Calcineurin Inhibitor Taper

被引：0
|
作者：
Elmasri, A. [1 ]
Valdepenas, B. [1 ]
Benken, S. [1 ]
Hajjiri, Z. [2 ]
Benken, J. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B202
引用
下载
收藏
页码：S845 / S846
页数：2
相关论文
共 50 条
  • [1] Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
    Tawhari, Ibrahim
    Hallak, Patrick
    Bin, Sofia
    Yamani, Fatmah
    Safar-Boueri, Maria
    Irshad, Aazib
    Leventhal, Joseph
    Ansari, Mohammed Javeed
    Cravedi, Paolo
    Gallon, Lorenzo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients.
    Muhsin, S. A.
    Safa, K.
    Gilligan, H. M.
    Heher, E. C.
    Williams, W. W.
    Wojciechowski, D. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 691 - 691
  • [3] Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
    Bredewold, Obbo W.
    Chan, Joe
    Svensson, My
    Bruchfeld, Annette
    de Fijter, Johan W.
    Furuland, Hans
    Grinyo, Josep M.
    Hartmann, Anders
    Holdaas, Hallvard
    Hellberg, Olof
    Jardine, Alan
    Mjornstedt, Lars
    Skov, Karin
    Smerud, Knut T.
    Soveri, Inga
    Sorensen, Soren S.
    van Zonneveld, Anton-Jan
    Fellstrom, Bengt
    KIDNEY MEDICINE, 2023, 5 (01)
  • [4] RESOLUTION OF CALCINEURIN INHIBITOR INDUCED PSYCHOSIS IN A KIDNEY TRANSPLANT RECIPIENT BY SWITCHING TO BELATACEPT
    Aramada, Harsha
    Kipp, Gretchen
    Rancurella, Michael
    Oleniacz, Shauna
    Zahid, Sohaib
    Sureshkumar, Kalathil
    Chopra, Bhavna
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 653 - 653
  • [5] Conversion to Belatacept for Calcineurin Inhibitor Toxicities.
    Patel, S. S.
    Jadav, P.
    Sekulic, M.
    Kudose, S.
    Batal, I.
    Mohan, S.
    Crew, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 513 - 514
  • [6] Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant Recipients
    Sethi, Supreet
    Najjar, Reiad
    Peng, Alice
    Choi, Jua
    Lim, Kathlyn
    Vo, Ashley
    Jordan, Stanley C.
    Huang, Edmund
    TRANSPLANTATION, 2020, 104 (07) : 1500 - 1507
  • [7] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [8] PREDICTORS OF GRAFT FUNCTION IMPROVEMENT AFTER CONVERSION FROM CALCINEURIN INHIBITORS TO BELATACEPT IN KIDNEY RECIPIENTS WITH CALCINEURIN INHIBITOR NEPHROTOXICITY
    Pievani, Daniele
    Viglietti, Denis
    Louis, Kevin
    Glotz, Denis
    Legendre, Christophe
    Loupy, Alexandre
    Lefaucheur, Carmen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 645 - 645
  • [9] Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
    Mira Choi
    Friederike Bachmann
    Kaiyin Wu
    Nils Lachmann
    Danilo Schmidt
    Susanne Brakemeier
    Michael Duerr
    Andreas Kahl
    Kai-Uwe Eckardt
    Klemens Budde
    Peter Nickel
    BMC Nephrology, 21
  • [10] MICROVASCULAR INFLAMMATION IS A RISK FACTOR IN KIDNEY TRANSPLANT RECIPIENTS WITH VERY LATE CONVERSION FROM CALCINEURIN INHIBITOR-BASED REGIMENS TO BELATACEPT
    Choi, M.
    Bachmann, F.
    Kahl, A.
    Schmidt, D.
    Budde, K.
    Eckardt, K. -U.
    Brakemeier, S.
    Duerr, M.
    Wu, K.
    Lachmann, N.
    Nickel, P.
    TRANSPLANT INTERNATIONAL, 2020, 33 : 11 - 11
12345